| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b5a5346d24a672ddf096b72398c0011 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 |
| filingDate |
2022-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e8f404c0c7b58d43694e329acca6b14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e1973598becac03f83142a968fabffb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89c5d207565a5dd12766950d57fbc864
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f483c3a8367397ab94c3f1aad7f9e5f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1435d780ea58421861e1588bb7ff05c |
| publicationDate |
2022-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114410590-A |
| titleOfInvention |
Hybridoma cell strain secreting glucagon monoclonal antibody, monoclonal antibody and application thereof |
| abstract |
The invention relates to the technical field of biology, and particularly discloses a glucagon secretion monoclonal antibody hybridoma cell strain, a monoclonal antibody thereof and application thereof. The hybridoma cell strain comprises a cell strain with a preservation number of GDMCC NO: 62086 hybridoma cell strain GLU-N2-6 with the preservation number of GDMCC NO: 61986 hybridoma cell line MM 02H. The invention obtains two monoclonal antibodies aiming at different antigen epitopes of glucagon by obtaining hybridoma cell strains (hybridoma cell strain GLU-N2-6 and hybridoma cell strain MM02H) secreting anti-glucagon monoclonal antibodies, the monoclonal antibodies have higher specificity, affinity and potency, and can detect the glucagon content in serum or plasma through pairing, and the monoclonal antibodies are applied to the detection of glucagon content change or the diagnosis of products of diseases characterized by glucagon abnormal expression. |
| priorityDate |
2022-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |